Cost-utility analysis of current COVID-19 vaccination program recommendations in Canada

doi:10.1016/j.jvacx.2025.100660

Cost-utility analysis of current COVID-19 vaccination program recommendations in Canada

2025-06-01

0

OA

AI

Gebremedhin Beedemariam Gebretekle

DOI：10.1016/j.jvacx.2025.100660

Original

Original request for help

Save

Abstract

En 中文

As COVID-19 becomes established as an endemic disease with widespread population immunity, there is uncertainty about the economic benefit of ongoing COVID-19 vaccination programs. We assessed the cost-effectiveness of a COVID-19 vaccination program similar to current Canadian recommendations, modelled as annual vaccination for people aged less than 65 years with chronic medical conditions and biannual vaccination for adults aged 65 years and older.

Keywords:

COVID-19

SARS-CoV-2

Vaccine

Health economics

Cost-effectiveness analysis

Cost-utility analysis of current COVID-19 vaccination program recommendations in Canada

Abstract

Journal

Organization